These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12092139)

  • 1. The prevalence of the owner of serologic markers for the hepatitis C virus, in a north-eastern territory of Romania.
    Azoicăi D; Ivan A; Carasievici E; Luca V; Ilcenco D; Scripcaru L; Scripcariu D; Grigoriu-Merchez M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):127-31. PubMed ID: 12092139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The epidemiological aspects and prevalence of markers in those with viral hepatitis C in some population categories in 1994-1997 in Iaşi County].
    Ivan A; Azoicăi D; Filimon R; Scripcaru L; Stefanache F; Luca V; Scripcariu D; Chiriac L; Iacob E; Calangiu E
    Bacteriol Virusol Parazitol Epidemiol; 1998; 43(4):275-9. PubMed ID: 10422324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya.
    Ilako FM; McLigeyo SO; Riyat MS; Lule GN; Okoth FA; Kaptich D
    East Afr Med J; 1995 Jun; 72(6):362-4. PubMed ID: 7498004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.
    Araj GF; Kfoury-Baz EE; Barada KA; Nassif RE; Alami SY
    J Med Liban; 1995; 43(1):11-6. PubMed ID: 8676356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases.
    Panigrahi AK; Panda SK; Dixit RK; Rao KV; Acharya SK; Dasarathy S; Nanu A
    J Med Virol; 1997 Mar; 51(3):167-74. PubMed ID: 9139079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus in plasmapheresis donors].
    Padrón GJ; Rodríguez Z; Rivera L; Arús E; Beltrán J; Roca J; Pantaleón B
    Sangre (Barc); 1995 Jun; 40(3):187-90. PubMed ID: 7570270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.